Hudson Bay Capital Management
SPHS

Hudson Bay Capital Management’s Sophiris Bio, Inc. SPHS Stock Holding History

Hudson Bay Capital Management’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-32,143
Closed -$90K – 990
2016
Q4 		$90K Hold
32,143
– – ﹤0.01% 604
2016
Q3 		$100K Buy
+32,143
New +$121K ﹤0.01% 413

Other funds holding SPHS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SMV
Sofinnova Management VIII Menlo Park, California $183M AUM 4.18% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Hudson Bay Capital Management's SPHS Position: Q1 2017 in Review

Hudson Bay Capital Management sold out of Sophiris Bio, Inc. (SPHS) in Q1 2017, closing a stake of 32,143 shares — an estimated $90K sold.

Hudson Bay Capital Management first reported a position in SPHS in Q3 2016 and held it in 2 quarters. The position peaked at $100K in Q3 2016. 31 funds tracked by Wall St. Rank hold SPHS as of Q1 2017.

  • Hudson Bay Capital Management reported no remaining Sophiris Bio, Inc. position as of Q1 2017 after selling out during the quarter.
  • Hudson Bay Capital Management sold 32,143 Sophiris Bio, Inc. shares in Q1 2017, an estimated $90K.
  • Hudson Bay Capital Management first reported a position in Sophiris Bio, Inc. in Q3 2016 and held it in 2 quarters.
  • Hudson Bay Capital Management's Sophiris Bio, Inc. position peaked at $100K in Q3 2016.
  • 31 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2017.

Based on Hudson Bay Capital Management's 13F filing for Q1 2017, filed 15 May 2017.